{"content":"<li class=\"n-box-item date-title\" data-end=\"1342497599\" data-start=\"1342411200\" data-txt=\"Wednesday, December 18, 2019\">Monday, July 16, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"417301\" data-ts=\"1342476685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFRM\" target=\"_blank\">MFRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417301\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattress Firm&#39;s (NASDAQ:MFRM) Q2 warning takes a toll on other mattress stocks. TPX -6.1%. SCSS...</a></h4> Mattress Firm's (NASDAQ:<a href='https://seekingalpha.com/symbol/MFRM' title='Mattress Firm Holding Corp.'>MFRM</a>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/417071\">Q2 warning</a> takes a toll on other mattress stocks. <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color=\"red\">-6.1%</font>. SCSS <font color=\"red\">-7.4%</font>. The warning comes 6 weeks after Tempur Pedic <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/353921\">cut</a> its 2012 sales outlook, and bolsters <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/391251\">bear arguments</a> about weakening consumer demand. <a href='https://seekingalpha.com/symbol/MFRM' title='Mattress Firm Holding Corp.'>MFRM</a> now <font color=\"red\">-12.5%</font> AH. <div class=\"tiny-share-widget\" data-id=\"417301\" data-linked=\"Mattress Firm&#39;s (NASDAQ:MFRM) Q2 warning takes a toll on other mattress stocks. TPX -6.1%. SCSS...\" data-tweet=\"$MFRM $MFRM $TPX - Mattress Firm&#39;s (NASDAQ:MFRM) Q2 warning takes a toll on other mattress stocks. TPX -6.1%. SCSS -7.4%. The warning comes 6 weeks after Tempur Pedic cut its 2012 sales outlook, and bolsters bear arguments about weakening consumer deman... https://seekingalpha.com/news/417301?source=tweet\" data-url=\"https://seekingalpha.com/news/417301\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417241\" data-ts=\"1342474951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGIT\" target=\"_blank\">DGIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Generation (NASDAQ:DGIT) has resumed trading after announcing it would explore strategic...</a></h4> Digital Generation (NASDAQ:<a href='https://seekingalpha.com/symbol/DGIT' title='Digital Generation, Inc.'>DGIT</a>) has resumed trading after announcing it would <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/417021\">explore strategic alternatives</a>. Shares <font color=\"green\">+19.7%</font> AH to $11.50. <div class=\"tiny-share-widget\" data-id=\"417241\" data-linked=\"Digital Generation (NASDAQ:DGIT) has resumed trading after announcing it would explore strategic...\" data-tweet=\"$DGIT - Digital Generation (NASDAQ:DGIT) has resumed trading after announcing it would explore strategic alternatives. Shares +19.7% AH to $11.50. https://seekingalpha.com/news/417241?source=tweet\" data-url=\"https://seekingalpha.com/news/417241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417231\" data-ts=\"1342474710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus Biosciences (APRI) files a 3.7M share registration statement. Stock -5.6% AH.</a></h4><p>Apricus Biosciences (APRI) <a target=\"_blank\" href=\"http://www.sec.gov/Archives/edgar/data/1017491/000114420412039699/v318703_s8.htm\">files a 3.7M share registration statement</a>. Stock <font color=\"red\">-5.6%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"417231\" data-linked=\"Apricus Biosciences (APRI) files a 3.7M share registration statement. Stock -5.6% AH. \" data-tweet=\"$SEEL - Apricus Biosciences (APRI) files a 3.7M share registration statement. Stock -5.6% AH. https://seekingalpha.com/news/417231?source=tweet\" data-url=\"https://seekingalpha.com/news/417231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417211\" data-ts=\"1342474165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKG\" target=\"_blank\">PKG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Packaging of America (NYSE:PKG): Q2 EPS of $0.49 beats by $0.04. Revenue of $712M (+7.1% Y/Y)...</a></h4><b>Packaging of America (NYSE:<a href=\"https://seekingalpha.com/symbol/PKG\" title=\"Packaging Corporation Of America\">PKG</a>):</b> Q2 EPS of $0.49 <font color=\"green\">beats by $0.04</font>. Revenue of $712M (+7.1% Y/Y) <font color=\"green\">beats by $21M</font>. Shares <font color=\"green\">+3.3%</font> AH. (PR) <div class=\"tiny-share-widget\" data-id=\"417211\" data-linked=\"Packaging of America (NYSE:PKG): Q2 EPS of $0.49 beats by $0.04. Revenue of $712M (+7.1% Y/Y)...\" data-tweet=\"$PKG - Packaging of America (NYSE:PKG): Q2 EPS of $0.49 beats by $0.04. Revenue of $712M (+7.1% Y/Y) beats by $21M. Shares +3.3% AH. (PR) https://seekingalpha.com/news/417211?source=tweet\" data-url=\"https://seekingalpha.com/news/417211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417161\" data-ts=\"1342472940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAST\" target=\"_blank\">CAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417161\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of ChinaCast Education (OTCPK:CAST) are getting hit after saying its former VP Shi...</a></h4><p>Shares of ChinaCast Education (<a href=\"https://seekingalpha.com/symbol/CAST\" title=\"ChinaCast Education Corp.\">OTCPK:CAST</a>) are getting hit after saying its former VP Shi Shicheng has been <a target=\"_blank\" href=\"http://www.sec.gov/Archives/edgar/data/1261888/000114420412039615/v318607_8k.htm\">detained by police</a> since mid-June on suspected involvement in loan fraud and misappropriation of school funds during the period from 2009 and 2012. The company has obtained bank statements indicating there may have been a series of cash transfers between Mr. Shi Shicheng\u2019s son, Shi Qinyan, and the company that were not authorized by the company\u2019s board of directors. Shares <font color=\"red\">-7.8%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"417161\" data-linked=\"Shares of ChinaCast Education (OTCPK:CAST) are getting hit after saying its former VP Shi...\" data-tweet=\"$CAST - Shares of ChinaCast Education (OTCPK:CAST) are getting hit after saying its former VP Shi Shicheng has been detained by police since mid-June on suspected involvement in loan fraud and misappropriation of school funds during the period from 2009... https://seekingalpha.com/news/417161?source=tweet\" data-url=\"https://seekingalpha.com/news/417161\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417101\" data-ts=\"1342471927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheniere Energy (NYSEMKT:LNG) -4.4% AH following its announcement of a 20M share common stock...</a></h4><p>Cheniere Energy (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/LNG\" title=\"Cheniere Energy, Inc\">LNG</a>) <font color=\"red\">-4.4%</font> AH following its announcement of a 20M share common stock offering. LNG says it intends to use the net proceeds to repay  the $204M principal amount outstanding of the 2.25% convertible  notes due Aug. 1, 2012, for capital expenditures on the Creole Trail  Pipeline and for general corporate purposes. </p><div class=\"tiny-share-widget\" data-id=\"417101\" data-linked=\"Cheniere Energy (NYSEMKT:LNG) -4.4% AH following its announcement of a 20M share common stock...\" data-tweet=\"$LNG - Cheniere Energy (NYSEMKT:LNG) -4.4% AH following its announcement of a 20M share common stock offering. LNG says it intends to use the net proceeds to repay the $204M principal amount outstanding of the 2.25% convertible notes due Aug. 1, 2012, f... https://seekingalpha.com/news/417101?source=tweet\" data-url=\"https://seekingalpha.com/news/417101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417081\" data-ts=\"1342471804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRO\" target=\"_blank\">BRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brown &amp;amp; Brown (NYSE:BRO): Q2 EPS of $0.26 misses by $0.05. Revenue of $290.9M (+17.9% Y/Y)...</a></h4><b>Brown &amp; Brown (NYSE:<a href=\"https://seekingalpha.com/symbol/BRO\" title=\"Brown &amp; Brown Insurance\">BRO</a>):</b> Q2 EPS of $0.26 <font color=\"red\">misses by $0.05</font>. Revenue of $290.9M (+17.9% Y/Y) <font color=\"red\">misses by $4M</font>. Shares <font color=\"red\">-1.9%</font> AH. (PR) <div class=\"tiny-share-widget\" data-id=\"417081\" data-linked=\"Brown &amp;amp; Brown (NYSE:BRO): Q2 EPS of $0.26 misses by $0.05. Revenue of $290.9M (+17.9% Y/Y)...\" data-tweet=\"$BRO - Brown &amp; Brown (NYSE:BRO): Q2 EPS of $0.26 misses by $0.05. Revenue of $290.9M (+17.9% Y/Y) misses by $4M. Shares -1.9% AH. (PR) https://seekingalpha.com/news/417081?source=tweet\" data-url=\"https://seekingalpha.com/news/417081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417071\" data-ts=\"1342471706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFRM\" target=\"_blank\">MFRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Mattress Firm (NASDAQ:MFRM) are getting hammered in after-hours trading, now down over...</a></h4><p>Shares of Mattress Firm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MFRM\" title=\"Mattress Firm Holding Corp.\">MFRM</a>) are getting hammered in after-hours trading, now down over 7.7% after lowering its sales outlook. The firm now expects to earn a Q2 EPS $0.27 - $0.29, below previous estimates of $0.26 - $0.29. Sales are now expected be come in around $270M - $275M, missing expectations of $274M. Shares <font color=\"red\">-7.7%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"417071\" data-linked=\"Shares of Mattress Firm (NASDAQ:MFRM) are getting hammered in after-hours trading, now down over...\" data-tweet=\"$MFRM - Shares of Mattress Firm (NASDAQ:MFRM) are getting hammered in after-hours trading, now down over 7.7% after lowering its sales outlook. The firm now expects to earn a Q2 EPS $0.27 - $0.29, below previous estimates of $0.26 - $0.29. Sales are now... https://seekingalpha.com/news/417071?source=tweet\" data-url=\"https://seekingalpha.com/news/417071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417061\" data-ts=\"1342471271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417061\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk (NASDAQ:SPLK) -4.1% AH after providing details about a previously-announced stock...</a></h4><p>Splunk (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPLK\" title=\"Splunk Inc.\">SPLK</a>) <font color=\"red\">-4.1%</font> AH after <a target=\"_blank\" href=\"http://sec.gov/Archives/edgar/data/1353283/000104746912007216/a2210222zs-1a.htm\">providing details</a> about a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/390001\">previously-announced</a> stock offering to be made on behalf of insiders. 11.7M shares will be sold, and those selling include VC investors and chairman/CEO Godfrey R. Sullivan. The company's IPO share lock-up expires on October 16. </p><div class=\"tiny-share-widget\" data-id=\"417061\" data-linked=\"Splunk (NASDAQ:SPLK) -4.1% AH after providing details about a previously-announced stock...\" data-tweet=\"$SPLK - Splunk (NASDAQ:SPLK) -4.1% AH after providing details about a previously-announced stock offering to be made on behalf of insiders. 11.7M shares will be sold, and those selling include VC investors and chairman/CEO Godfrey R. Sullivan. The compa... https://seekingalpha.com/news/417061?source=tweet\" data-url=\"https://seekingalpha.com/news/417061\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417041\" data-ts=\"1342471159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Peregrine Pharmaceuticals (PPHM): FQ4 beats on a per share basis, but comes up short on...</a></h4><p>More on Peregrine Pharmaceuticals (PPHM): <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/416911\">FQ4 beats</a> on a per share basis, but comes up short on revenue due to a 23% Y/Y decline in total sales. Total revenues for FY12  were  $15.2M however, compared to $13.5M in the prior year period. The Y/Y increase was primarily attributed to a boost in contract manufacturing revenue from its subsidiary Avid Bioservices. Shares <font color=\"green\">+2.8%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"417041\" data-linked=\"More on Peregrine Pharmaceuticals (PPHM): FQ4 beats on a per share basis, but comes up short on...\" data-tweet=\"$CDMO - More on Peregrine Pharmaceuticals (PPHM): FQ4 beats on a per share basis, but comes up short on revenue due to a 23% Y/Y decline in total sales. Total revenues for FY12 were $15.2M however, compared to $13.5M in the prior year period. The Y/Y in... https://seekingalpha.com/news/417041?source=tweet\" data-url=\"https://seekingalpha.com/news/417041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"417011\" data-ts=\"1342470212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDXS\" target=\"_blank\">CDXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/417011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Codexis (NASDAQ:CDXS) +11.4% AH after signing an exclusive negotiation agreement with Royal...</a></h4><p>Codexis (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CDXS\" title=\"Codexis, Inc.\">CDXS</a>) <font color=\"green\">+11.4%</font> AH after signing an exclusive negotiation agreement with Royal Dutch Shell (<a href=\"https://seekingalpha.com/symbol/RDS.A\" title=\"Royal Dutch Shell plc\">RDS.A</a>, <a href=\"https://seekingalpha.com/symbol/RDS.B\" title=\"Royal Dutch Shell plc\">RDS.B</a>) which would grant to CDXS certain rights and licenses in the biofuels field to develop and sell cellulase enzymes to third parties on a worldwide basis except Brazil. </p><div class=\"tiny-share-widget\" data-id=\"417011\" data-linked=\"Codexis (NASDAQ:CDXS) +11.4% AH after signing an exclusive negotiation agreement with Royal...\" data-tweet=\"$CDXS $CDXS $RDS.A - Codexis (NASDAQ:CDXS) +11.4% AH after signing an exclusive negotiation agreement with Royal Dutch Shell (RDS.A, RDS.B) which would grant to CDXS certain rights and licenses in the biofuels field to develop and sell cellulase enzymes... https://seekingalpha.com/news/417011?source=tweet\" data-url=\"https://seekingalpha.com/news/417011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416921\" data-ts=\"1342469259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICUI\" target=\"_blank\">ICUI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416921\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ICU Medical (NASDAQ:ICUI): FQ2 EPS of $0.63 beats by $0.03. Revenue of $77.3M (-0.6% Y/Y) misses...</a></h4><b>ICU Medical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ICUI\" title=\"ICU Medical, Inc.\">ICUI</a>):</b> FQ2 EPS of $0.63 <font color=\"green\">beats by $0.03</font>. Revenue of $77.3M (-0.6% Y/Y) <font color=\"red\">misses by $0.7M</font>. Shares <font color=\"red\">-2.9%</font> AH. (PR) <div class=\"tiny-share-widget\" data-id=\"416921\" data-linked=\"ICU Medical (NASDAQ:ICUI): FQ2 EPS of $0.63 beats by $0.03. Revenue of $77.3M (-0.6% Y/Y) misses...\" data-tweet=\"$ICUI - ICU Medical (NASDAQ:ICUI): FQ2 EPS of $0.63 beats by $0.03. Revenue of $77.3M (-0.6% Y/Y) misses by $0.7M. Shares -2.9% AH. (PR) https://seekingalpha.com/news/416921?source=tweet\" data-url=\"https://seekingalpha.com/news/416921\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416901\" data-ts=\"1342469142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AABA\" target=\"_blank\">AABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416901\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In a stunner, Marissa Mayer, the head of Google&#39;s local services ops, has been named the new CEO...</a></h4><p>In a stunner, Marissa Mayer, the head of Google's local services ops, has been named the <a target=\"_blank\" href=\"http://dealbook.nytimes.com/2012/07/16/googles-marissa-mayer-tapped-as-yahoos-chief/?smid=tw-nytimesdealbook&amp;seid=auto\">new CEO</a> of Yahoo, instead of interim CEO Ross Levinsohn. YHOO <font color=\"green\">+3.6%</font> AH. <a href=\"https://seekingalpha.com/symbol/GOOG\" title=\"Alphabet, Inc. Cl C\">GOOG</a> <font color=\"red\">-0.5%</font>. <strong>Update: </strong>Yahoo has issued a PR confirming the move. </p><div class=\"tiny-share-widget\" data-id=\"416901\" data-linked=\"In a stunner, Marissa Mayer, the head of Google&#39;s local services ops, has been named the new CEO...\" data-tweet=\"$AABA $AABA $GOOG - In a stunner, Marissa Mayer, the head of Google&#39;s local services ops, has been named the new CEO of Yahoo, instead of interim CEO Ross Levinsohn. YHOO +3.6% AH. GOOG -0.5%. Update: Yahoo has issued a PR confirming the move. https://seekingalpha.com/news/416901?source=tweet\" data-url=\"https://seekingalpha.com/news/416901\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416881\" data-ts=\"1342468996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.B. Hunt Transport Services (NASDAQ:JBHT): Q2 EPS of $0.67 beats by $0.01. Revenue of $1.26B...</a></h4><b>J.B. Hunt Transport Services (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JBHT\" title=\"J.B. Hunt Transport Services, Inc.\">JBHT</a>):</b> Q2 EPS of $0.67 <font color=\"green\">beats by $0.01</font>. Revenue of $1.26B (+10% Y/Y) <font color=\"red\">misses by $40M</font>. Shares <font color=\"red\">-1.8%</font> AH. (PR) <div class=\"tiny-share-widget\" data-id=\"416881\" data-linked=\"J.B. Hunt Transport Services (NASDAQ:JBHT): Q2 EPS of $0.67 beats by $0.01. Revenue of $1.26B...\" data-tweet=\"$JBHT - J.B. Hunt Transport Services (NASDAQ:JBHT): Q2 EPS of $0.67 beats by $0.01. Revenue of $1.26B (+10% Y/Y) misses by $40M. Shares -1.8% AH. (PR) https://seekingalpha.com/news/416881?source=tweet\" data-url=\"https://seekingalpha.com/news/416881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416871\" data-ts=\"1342468792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WOOF\" target=\"_blank\">WOOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">It&#39;s a dog day afternoon for animal health care companies VCA&amp;nbsp;Antech (WOOF -7.1%) and...</a></h4> It's a dog day afternoon for animal health care companies VCA&nbsp;Antech (<a href='https://seekingalpha.com/symbol/WOOF' title='VCA Antech, Inc.'>WOOF</a> <font color=\"red\">-7.1%</font>) and MWI&nbsp;Veterinary (<a href='https://seekingalpha.com/symbol/MWIV' title='MWI Veterinary Supply, Inc.'>MWIV</a> <font color=\"red\">-5.1%</font>) after William Blair is <a target=\"_blank\" href=\"http://www.theflyonthewall.com/permalinks/entry.php/WOOFid1667606/WOOF-VCA-Antech-sinks-after-firm-says-sales-growth-likely-slowed\">bearish</a> on their upcoming earnings results,  noting a warm winter and early start to the flea and tick season that  drew sales forward from the latest quarter. <div class=\"tiny-share-widget\" data-id=\"416871\" data-linked=\"It&#39;s a dog day afternoon for animal health care companies VCA&amp;nbsp;Antech (WOOF -7.1%) and...\" data-tweet=\"$WOOF $WOOF $MWIV - It&#39;s a dog day afternoon for animal health care companies VCA&amp;nbsp;Antech (WOOF -7.1%) and MWI&amp;nbsp;Veterinary (MWIV -5.1%) after William Blair is bearish on their upcoming earnings results, noting a warm winter and early start to th... https://seekingalpha.com/news/416871?source=tweet\" data-url=\"https://seekingalpha.com/news/416871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416821\" data-ts=\"1342467091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu (SVU +9.2%) extends gains following a WSJ article that the company expects to begin...</a></h4><p>Supervalu (<a href=\"https://seekingalpha.com/symbol/SVU\" title=\"SUPERVALU Inc.\">SVU</a> <font color=\"green\">+9.2%</font>) extends gains following a <em>WSJ</em> article that the company expects to begin sending out financial information in the coming days to <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424052702304388004577531122632099062.html\">prospective buyers,</a> including buyout firms and other supermarket operators and distributors. SVU said <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/410671\">last week</a> it had hired bankers to look at selling either part or all of itself. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415761\">earlier</a>) </p><div class=\"tiny-share-widget\" data-id=\"416821\" data-linked=\"Supervalu (SVU +9.2%) extends gains following a WSJ article that the company expects to begin...\" data-tweet=\"$SVU - Supervalu (SVU +9.2%) extends gains following a WSJ article that the company expects to begin sending out financial information in the coming days to prospective buyers, including buyout firms and other supermarket operators and distributors. SVU... https://seekingalpha.com/news/416821?source=tweet\" data-url=\"https://seekingalpha.com/news/416821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416781\" data-ts=\"1342465842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMCR\" target=\"_blank\">GMCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416781\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Green Mountain Coffee (NASDAQ:GMCR) stay on their downward spiral to trade 8.4% lower...</a></h4><p>Shares of Green Mountain Coffee (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GMCR\" title=\"Keurig Green Mountain Inc\">GMCR</a>) stay on their downward spiral to trade <font color=\"red\">8.4% lower</font> at $18.04 a pop. With no news of note out on the company, investors may be getting jittery about holding the much-maligned stock ahead of GMCR's <a target=\"_blank\" href=\"http://investor.gmcr.com/releases.cfm\">FQ3 report </a> scheduled to be released later this month or in early August.</p><div class=\"tiny-share-widget\" data-id=\"416781\" data-linked=\"Shares of Green Mountain Coffee (NASDAQ:GMCR) stay on their downward spiral to trade 8.4% lower...\" data-tweet=\"$GMCR - Shares of Green Mountain Coffee (NASDAQ:GMCR) stay on their downward spiral to trade 8.4% lower at $18.04 a pop. With no news of note out on the company, investors may be getting jittery about holding the much-maligned stock ahead of GMCR&#39;s FQ3 ... https://seekingalpha.com/news/416781?source=tweet\" data-url=\"https://seekingalpha.com/news/416781\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416751\" data-ts=\"1342464745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSX\" target=\"_blank\">PSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phillips 66 (PSX +2.3%) adds to Friday&#39;s Buffett-fueled gains as Oppenheimer starts coverage at...</a></h4><p>Phillips 66 (<a href=\"https://seekingalpha.com/symbol/PSX\" title=\"Phillips 66\">PSX</a> <font color=\"green\">+2.3%</font>) adds to Friday's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/413881\">Buffett-fueled gains</a> as Oppenheimer <a target=\"_blank\" href=\"http://www.dividend.com/blog/?p=49988\">starts coverage</a> at Outperform with a $42 price target. The firm likes PSX's strategy of de-emphasizing refining while aggressively expanding in gas processing and petrochemicals, believing the asset mix, large scale and balanced operations offer a competitive advantage throughout the business cycle. </p><div class=\"tiny-share-widget\" data-id=\"416751\" data-linked=\"Phillips 66 (PSX +2.3%) adds to Friday&#39;s Buffett-fueled gains as Oppenheimer starts coverage at...\" data-tweet=\"$PSX - Phillips 66 (PSX +2.3%) adds to Friday&#39;s Buffett-fueled gains as Oppenheimer starts coverage at Outperform with a $42 price target. The firm likes PSX&#39;s strategy of de-emphasizing refining while aggressively expanding in gas processing and petroc... https://seekingalpha.com/news/416751?source=tweet\" data-url=\"https://seekingalpha.com/news/416751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416731\" data-ts=\"1342464581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSG\" target=\"_blank\">MSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Madison Square Garden (MSG -1.8%) trade lower after the New York Knicks sign an...</a></h4><p>Shares of Madison Square Garden (<a href=\"https://seekingalpha.com/symbol/MSG\" title=\"The Madison Square Garden Company\">MSG</a> <font color=\"red\">-1.8%</font>) trade lower after the New York Knicks <a target=\"_blank\" href=\"http://espn.go.com/dallas/nba/story/_/id/8168185/2012-nba-free-agency-new-york-knicks-match-jeremy-lin-houston-rockets-offer-sheet-sources-say\">sign</a> an apparent replacement for player Jeremy Lin - despite the boost Linsanity provided on and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=linsanity\">off the court</a> last season. Cynics <a target=\"_blank\" href=\"http://twitter.com/thetellblog/status/224934474813669376\">note</a> that the company has lost off its market cap in today's action more than the equivalent of matching an offer for Lin's services from an opposing team. </p><div class=\"tiny-share-widget\" data-id=\"416731\" data-linked=\"Shares of Madison Square Garden (MSG -1.8%) trade lower after the New York Knicks sign an...\" data-tweet=\"$MSG - Shares of Madison Square Garden (MSG -1.8%) trade lower after the New York Knicks sign an apparent replacement for player Jeremy Lin - despite the boost Linsanity provided on and off the court last season. Cynics note that the company has lost of... https://seekingalpha.com/news/416731?source=tweet\" data-url=\"https://seekingalpha.com/news/416731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416701\" data-ts=\"1342463705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXP\" target=\"_blank\">AXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of American Express (AXP +1.3%) also enjoy a boost following the settlement between rival...</a></h4><p>Shares of American Express (<a href=\"https://seekingalpha.com/symbol/AXP\" title=\"American Express Company\">AXP</a> <font color=\"green\">+1.3%</font>) also <a target=\"_blank\" href=\"http://www.marketwatch.com/story/amex-gets-lift-from-card-issuer-settlement-2012-07-16\">enjoy a boost</a> following the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/416651\">settlement</a> between rival card issuers and retailers. AXP benefits because MasterCard and Visa would lower their fees less than expected and thus \"can continue to charge its current rates and won\u2019t see meaningful pricing pressure,\" Susquehanna says. Capital One (<a href=\"https://seekingalpha.com/symbol/COF\" title=\"Capital One Financial Corporation\">COF</a> <font color=\"green\">+2.3%</font>) also should benefit. </p><div class=\"tiny-share-widget\" data-id=\"416701\" data-linked=\"Shares of American Express (AXP +1.3%) also enjoy a boost following the settlement between rival...\" data-tweet=\"$AXP $AXP $COF - Shares of American Express (AXP +1.3%) also enjoy a boost following the settlement between rival card issuers and retailers. AXP benefits because MasterCard and Visa would lower their fees less than expected and thus &quot;can continue to ch... https://seekingalpha.com/news/416701?source=tweet\" data-url=\"https://seekingalpha.com/news/416701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416651\" data-ts=\"1342462430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/V\" target=\"_blank\">V</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416651\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The settlement between merchants and credit card firms isn&#39;t only a win for merchants, as...</a></h4> The <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/414761\">settlement</a> between merchants and credit card firms isn't only a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415431\">win for merchants</a>, as Deutsche Bank's Bryan Keane argues it's also time for investors to \"<a target=\"_blank\" href=\"http://blogs.barrons.com/stockstowatchtoday/2012/07/16/buy-mastercard-and-visa-aggressively-on-merchant-settlement-analyst/\">aggressively buy</a>\" Visa (<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a> <font color=\"green\">+2%</font>) and MasterCard (<a href='https://seekingalpha.com/symbol/MA' title='Mastercard, Inc.'>MA</a> <font color=\"green\">+2%</font>): \"The agreement does nothing to increase competition (e.g., freedom of routing) or damage the networks&rsquo; dominant positions... a big risk [is] removed.\" <div class=\"tiny-share-widget\" data-id=\"416651\" data-linked=\"The settlement between merchants and credit card firms isn&#39;t only a win for merchants, as...\" data-tweet=\"$V $V $MA - The settlement between merchants and credit card firms isn&#39;t only a win for merchants, as Deutsche Bank&#39;s Bryan Keane argues it&#39;s also time for investors to &quot;aggressively buy&quot; Visa (V +2%) and MasterCard (MA +2%): &quot;The agreement does nothing... https://seekingalpha.com/news/416651?source=tweet\" data-url=\"https://seekingalpha.com/news/416651\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416621\" data-ts=\"1342461677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOC\" target=\"_blank\">IOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterOil (IOC +6.6%) hits a new 52-week high after Raymond James reaffirms its Outperform rating...</a></h4><p>InterOil (<a href=\"https://seekingalpha.com/symbol/IOC\" title=\"InterOil Corporation\">IOC</a> <font color=\"green\">+6.6%</font>) hits a new 52-week high after Raymond James reaffirms its Outperform rating on the stock and <a target=\"_blank\" href=\"http://www.dailypolitical.com/finance/stock-market/raymond-james-reaffirms-outperform-rating-on-interoil-ioc.htm\">raises its price target</a> to $100 from $70. </p><div class=\"tiny-share-widget\" data-id=\"416621\" data-linked=\"InterOil (IOC +6.6%) hits a new 52-week high after Raymond James reaffirms its Outperform rating...\" data-tweet=\"$IOC - InterOil (IOC +6.6%) hits a new 52-week high after Raymond James reaffirms its Outperform rating on the stock and raises its price target to $100 from $70. https://seekingalpha.com/news/416621?source=tweet\" data-url=\"https://seekingalpha.com/news/416621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416581\" data-ts=\"1342460228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Vivus (VVUS +6.3%) are higher today in anticipation that the FDA will soon approve its...</a></h4><p>Shares of Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+6.3%</font>) are higher today in anticipation that the <a target=\"_blank\" href=\"https://seekingalpha.com/article/718321-vivus-getting-ready-for-fda-approval\">FDA will soon approve</a> its diet drug Qnexa. A decision is expected to be issued by the end of tomorrow. If approved, the drug - which was rejected initially in its first attempt - will be the second weight loss drug to be approved by the regulatory body in the past two months. </p><div class=\"tiny-share-widget\" data-id=\"416581\" data-linked=\"Shares of Vivus (VVUS +6.3%) are higher today in anticipation that the FDA will soon approve its...\" data-tweet=\"$VVUS - Shares of Vivus (VVUS +6.3%) are higher today in anticipation that the FDA will soon approve its diet drug Qnexa. A decision is expected to be issued by the end of tomorrow. If approved, the drug - which was rejected initially in its first attem... https://seekingalpha.com/news/416581?source=tweet\" data-url=\"https://seekingalpha.com/news/416581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416511\" data-ts=\"1342458164\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416511\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook (FB -4.3%), which had strongly outperformed the NASDAQ from early June to early July,...</a></h4> Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color=\"red\">-4.3%</font>), which had <a target=\"_blank\" href=\"http://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1342468800000&amp;chddm=10426&amp;chls=IntervalBasedLine&amp;cmpto=INDEXNASDAQ:.IXIC&amp;cmptdms=0&amp;q=NASDAQ:FB&amp;ntsp=0\">strongly outperformed</a> the NASDAQ from early June to early July, is notably underperforming today. Shares are now <font color=\"red\">off 11%</font> from their July 9 high. Evercore's Ken Sena, who <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/378121\">started coverage</a> with a Hold in June, thinks <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/407931\">recent weakness</a> in Zynga and Groupon is finally <a target=\"_blank\" href=\"http://www.cnbc.com/id/48197634?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&amp;par=yahoo\">catching up</a> to Facebook. <div class=\"tiny-share-widget\" data-id=\"416511\" data-linked=\"Facebook (FB -4.3%), which had strongly outperformed the NASDAQ from early June to early July,...\" data-tweet=\"$FB - Facebook (FB -4.3%), which had strongly outperformed the NASDAQ from early June to early July, is notably underperforming today. Shares are now off 11% from their July 9 high. Evercore&#39;s Ken Sena, who started coverage with a Hold in June, thinks r... https://seekingalpha.com/news/416511?source=tweet\" data-url=\"https://seekingalpha.com/news/416511\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416481\" data-ts=\"1342457672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wondering why Caterpillar (CAT -1.4%) still lags the market? Just blame it on oil says Motley...</a></h4><p>Wondering why Caterpillar (<a href=\"https://seekingalpha.com/symbol/CAT\" title=\"Caterpillar Inc.\">CAT</a> <font color=\"red\">-1.4%</font>) still lags the market? Just <a target=\"_blank\" href=\"http://beta.fool.com/liorc/2012/07/16/why-caterpillar-isnt-pulling-just-blame-it-oil/7003/?ticker=USO&amp;source=eogyholnk0000001\">blame it on oil</a> says Motley Fool contributor Lior Cohen. <a href=\"https://seekingalpha.com/symbol/CAT\" title=\"Caterpillar Inc.\">CAT</a> has benefited in the past from big moves in oil as firms ramped up demand for engines and turbines for petroleum applications, but as oil prices dwindled and demand faded over the recent quarter, investors remain more than a little bit queasy about the company's upcoming financial report. </p><div class=\"tiny-share-widget\" data-id=\"416481\" data-linked=\"Wondering why Caterpillar (CAT -1.4%) still lags the market? Just blame it on oil says Motley...\" data-tweet=\"$CAT - Wondering why Caterpillar (CAT -1.4%) still lags the market? Just blame it on oil says Motley Fool contributor Lior Cohen. CAT has benefited in the past from big moves in oil as firms ramped up demand for engines and turbines for petroleum applic... https://seekingalpha.com/news/416481?source=tweet\" data-url=\"https://seekingalpha.com/news/416481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416471\" data-ts=\"1342457493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Repros Therapeutics (RPRX +5.7%) will submit a design for a Phase II trial of an oral version of...</a></h4><p>Repros Therapeutics (<a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"green\">+5.7%</font>) <a target=\"_blank\" href=\"http://feeds.reuters.com/~r/reuters/governmentfilingsNews/~3/hqyM1vdO3mY/reprostherapeutics-tumordrug-idUSL4E8IG5Q620120716%0A\">will submit</a> a design for a Phase II trial of an oral version of its tumor drug Proellex in the next few days as the company attempts to persuade the FDA to lift a suspension on testing of the treatment. The FDA put a study of Proellex on hold in 2009 due to liver toxicity issues. </p><div class=\"tiny-share-widget\" data-id=\"416471\" data-linked=\"Repros Therapeutics (RPRX +5.7%) will submit a design for a Phase II trial of an oral version of...\" data-tweet=\"$RPRX - Repros Therapeutics (RPRX +5.7%) will submit a design for a Phase II trial of an oral version of its tumor drug Proellex in the next few days as the company attempts to persuade the FDA to lift a suspension on testing of the treatment. The FDA p... https://seekingalpha.com/news/416471?source=tweet\" data-url=\"https://seekingalpha.com/news/416471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416421\" data-ts=\"1342456812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNKN\" target=\"_blank\">DNKN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Dunkin&#39; Brands (DNKN +3.8%) run higher after Piper Jaffray&#39;s recent upgrade to an...</a></h4><p>Shares of Dunkin' Brands (<a href=\"https://seekingalpha.com/symbol/DNKN\" title=\"Dunkin' Brands\">DNKN</a> <font color=\"green\">+3.8%</font>) run higher after Piper Jaffray's recent upgrade to an <a target=\"_blank\" href=\"http://www.schaeffersresearch.com/commentary/content/blog/analyst+initiations+burger+king+dunkin+brands+and+phillips+66/trading_floor_blog.aspx?single=true&amp;blogid=111953\">Overweight rating</a> looks a little more impressive after it <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415971\">takes down</a> other restaurant chains. A common thread from DNKN bulls is that the headline P-E ratio looks pricey mainly due to one-time expenses the company will outlive, but is justifiable given the large growth track the company remains on.</p><div class=\"tiny-share-widget\" data-id=\"416421\" data-linked=\"Shares of Dunkin&#39; Brands (DNKN +3.8%) run higher after Piper Jaffray&#39;s recent upgrade to an...\" data-tweet=\"$DNKN - Shares of Dunkin&#39; Brands (DNKN +3.8%) run higher after Piper Jaffray&#39;s recent upgrade to an Overweight rating looks a little more impressive after it takes down other restaurant chains. A common thread from DNKN bulls is that the headline P-E ra... https://seekingalpha.com/news/416421?source=tweet\" data-url=\"https://seekingalpha.com/news/416421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416411\" data-ts=\"1342456734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDVN\" target=\"_blank\">MDVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416411\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg fingers Medivation (MDVN +4.1%) as a potential takeover target in its &quot;Real M&amp;amp;A&quot;...</a></h4><p>Bloomberg fingers Medivation (<a href=\"https://seekingalpha.com/symbol/MDVN\" title=\"Medivation, Inc.\">MDVN</a> <font color=\"green\">+4.1%</font>) as a <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-07-15/prostate-cancer-treatment-seen-drawing-medivation-bids-real-m-a.html\">potential takeover target</a>  in its \"Real M&amp;A\" column, which should really be entitled \"Fantasy  M&amp;A.\" The stock has quadrupled in the past year on excitement that  its enzalutamide treatment for prostate cancer will soon get FDA  approval and then become a blockbuster. \"It's...our obligation to remain  open to all available options,\" says Medivation. </p><div class=\"tiny-share-widget\" data-id=\"416411\" data-linked=\"Bloomberg fingers Medivation (MDVN +4.1%) as a potential takeover target in its &quot;Real M&amp;amp;A&quot;...\" data-tweet=\"$MDVN - Bloomberg fingers Medivation (MDVN +4.1%) as a potential takeover target in its &quot;Real M&amp;A&quot; column, which should really be entitled &quot;Fantasy M&amp;A.&quot; The stock has quadrupled in the past year on excitement that its enzalutamide treatment for prostat... https://seekingalpha.com/news/416411?source=tweet\" data-url=\"https://seekingalpha.com/news/416411\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416401\" data-ts=\"1342456543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNF\" target=\"_blank\">RNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416401\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rising corn prices (CORN +3.3%) continue to prove good news for shares of fertilizer products...</a></h4><a target=\"_blank\" href=\"http://www.marketwatch.com/story/corn-futures-up-for-a-third-straight-session-2012-07-16\">Rising corn prices</a> (<a href=\"https://seekingalpha.com/symbol/CORN\" title=\"Teucrium Corn ETF\">CORN</a> <font color=\"green\">+3.3%</font>) continue to prove <a target=\"_blank\" href=\"http://news.investors.com/article/618064/201207131442/rentech-nitrogen-benefits-from-corn-market.htm\">good news</a> for shares of fertilizer products maker Rentech Nitrogen Partners (<a href=\"https://seekingalpha.com/symbol/RNF\" title=\"Rentech Nitrogen Partners, L.P.\">RNF</a> <font color=\"green\">+5.4%</font>), up ~30% in the past month. Nitrogen fertilizer demand is driven by corn acreage and production  yields, which are in turn driven by corn prices and gross farm revenue  per acre. <div class=\"tiny-share-widget\" data-id=\"416401\" data-linked=\"Rising corn prices (CORN +3.3%) continue to prove good news for shares of fertilizer products...\" data-tweet=\"$RNF $CORN $RNF - Rising corn prices (CORN +3.3%) continue to prove good news for shares of fertilizer products maker Rentech Nitrogen Partners (RNF +5.4%), up ~30% in the past month. Nitrogen fertilizer demand is driven by corn acreage and production y... https://seekingalpha.com/news/416401?source=tweet\" data-url=\"https://seekingalpha.com/news/416401\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416371\" data-ts=\"1342455777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HD\" target=\"_blank\">HD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416371\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Home Depot (HD -1.2%) and Lowe&#39;s (LOW -2.6%) slump after a soft report for June retail...</a></h4>Shares of Home Depot (<a href='https://seekingalpha.com/symbol/HD' title='Home Depot, Inc.'>HD</a> <font color=\"red\">-1.2%</font>) and Lowe's (<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a> <font color=\"red\">-2.6%</font>) slump after a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415561\">soft report</a> for June retail store sales shows particular weakness in areas that could effect the DIY names. Building material sales fell to $23.65M during the month, from $24.05M in May.<div class=\"tiny-share-widget\" data-id=\"416371\" data-linked=\"Shares of Home Depot (HD -1.2%) and Lowe&#39;s (LOW -2.6%) slump after a soft report for June retail...\" data-tweet=\"$HD $HD $LOW - Shares of Home Depot (HD -1.2%) and Lowe&#39;s (LOW -2.6%) slump after a soft report for June retail store sales shows particular weakness in areas that could effect the DIY names. Building material sales fell to $23.65M during the month, fro... https://seekingalpha.com/news/416371?source=tweet\" data-url=\"https://seekingalpha.com/news/416371\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416351\" data-ts=\"1342455210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOF\" target=\"_blank\">BIOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416351\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">If prices for corn (CORN +3%) are rising and demand is falling, why are BioFuel Energy (BIOF...</a></h4><p>If prices for corn (<a href=\"https://seekingalpha.com/symbol/CORN\" title=\"Teucrium Corn ETF\">CORN</a> <font color=\"green\">+3%</font>) are rising and demand is falling, why are BioFuel Energy (<a href=\"https://seekingalpha.com/symbol/BIOF\" title=\"BioFuel Energy Corp.\">BIOF</a> <font color=\"green\">+25%</font>) and Pacific Ethanol (<a href=\"https://seekingalpha.com/symbol/PEIX\" title=\"Pacific Ethanol, Inc.\">PEIX</a> <font color=\"green\">+11.8%</font>) <a target=\"_blank\" href=\"http://247wallst.com/2012/07/16/the-ethanol-paradox-higher-prices-on-lower-demand/\">enjoying such big spikes</a> today? Production closures appear to have taken enough ethanol off the market to support rising costs of corn and put some profit back into ethanol makers, 24/7's Paul Ausick writes. </p><div class=\"tiny-share-widget\" data-id=\"416351\" data-linked=\"If prices for corn (CORN +3%) are rising and demand is falling, why are BioFuel Energy (BIOF...\" data-tweet=\"$BIOF $CORN $BIOF - If prices for corn (CORN +3%) are rising and demand is falling, why are BioFuel Energy (BIOF +25%) and Pacific Ethanol (PEIX +11.8%) enjoying such big spikes today? Production closures appear to have taken enough ethanol off the mark... https://seekingalpha.com/news/416351?source=tweet\" data-url=\"https://seekingalpha.com/news/416351\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416291\" data-ts=\"1342453693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZTCOY\" target=\"_blank\">ZTCOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Some telecom equipment names slump after ZTE (OTCPK:ZTCOY) becomes the latest vendor to warn....</a></h4> Some telecom equipment names slump after ZTE (<a href='https://seekingalpha.com/symbol/ZTCOY' title='Zte Corp. ADR'>OTCPK:ZTCOY</a>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415131\">becomes the latest vendor</a> to warn. <a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a> <font color=\"red\">-3.2%</font>. ALU <font color=\"red\">-3.1%</font>. <a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a> <font color=\"red\">-1.4%</font>. Particularly worrisome may be ZTE's <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424052702303933704577530511248118968.html\">remarks</a> about delayed orders from Chinese carriers, given how China, thanks to its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/215471\">heavy broadband spending</a>, has remained an area of strength amidst a soft telecom capex environment. ZTE has also emerged a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/286201\">top-5</a> mobile phone vendor, thanks partly to strong Android sales. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/409901\">Adtran</a>) (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/410611\">Calix</a>) (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/402971\">Acme Packet</a>) <div class=\"tiny-share-widget\" data-id=\"416291\" data-linked=\"Some telecom equipment names slump after ZTE (OTCPK:ZTCOY) becomes the latest vendor to warn....\" data-tweet=\"$ZTCOY $ZTCOY $CIEN - Some telecom equipment names slump after ZTE (OTCPK:ZTCOY) becomes the latest vendor to warn. CIEN -3.2%. ALU -3.1%. ERIC -1.4%. Particularly worrisome may be ZTE&#39;s remarks about delayed orders from Chinese carriers, given how Chin... https://seekingalpha.com/news/416291?source=tweet\" data-url=\"https://seekingalpha.com/news/416291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416281\" data-ts=\"1342453654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416281\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam Pharmaceuticals (NASDAQ:ALNY) now surging 37% on heavy volume following positive Phase I...</a></h4> Alnylam Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>) now <font color=\"green\">surging 37%</font> on heavy volume following <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415721\">positive</a> Phase I trial results for ALN-TTR02, a treatment for a genetic mutation of the transthyretin gene. The mutation <a target=\"_blank\" href=\"http://online.wsj.com/article/BT-CO-20120716-703605.html\">causes</a> a hereditary, systemic disease called ATTR, which can damage body organs and tissue such as the peripheral nerves and heart. <div class=\"tiny-share-widget\" data-id=\"416281\" data-linked=\"Alnylam Pharmaceuticals (NASDAQ:ALNY) now surging 37% on heavy volume following positive Phase I...\" data-tweet=\"$ALNY - Alnylam Pharmaceuticals (NASDAQ:ALNY) now surging 37% on heavy volume following positive Phase I trial results for ALN-TTR02, a treatment for a genetic mutation of the transthyretin gene. The mutation causes a hereditary, systemic disease called... https://seekingalpha.com/news/416281?source=tweet\" data-url=\"https://seekingalpha.com/news/416281\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416241\" data-ts=\"1342452495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANDE\" target=\"_blank\">ANDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Andersons (ANDE -3.27%) slide today over fears of a worsening drought in the U.S....</a></h4> Shares of  Andersons (<a href='https://seekingalpha.com/symbol/ANDE' title='The Andersons, Inc.'>ANDE</a> <font color=\"red\">-3.27%</font>) slide today over fears of a <a target=\"_blank\" href=\"http://www.cnn.com/2012/07/13/us/midwest-drought/index.html\">worsening drought</a> in the U.S. Midwest. With the majority of the company's operations located in the eastern Midwest - where the drought is particularly acute -investors appear to be focusing on Andersons's reliance on corn for its ethanol plants. <div class=\"tiny-share-widget\" data-id=\"416241\" data-linked=\"Shares of Andersons (ANDE -3.27%) slide today over fears of a worsening drought in the U.S....\" data-tweet=\"$ANDE - Shares of Andersons (ANDE -3.27%) slide today over fears of a worsening drought in the U.S. Midwest. With the majority of the company&#39;s operations located in the eastern Midwest - where the drought is particularly acute -investors appear to be f... https://seekingalpha.com/news/416241?source=tweet\" data-url=\"https://seekingalpha.com/news/416241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416131\" data-ts=\"1342450744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISR\" target=\"_blank\">ISR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcap Med-tech company IsoRay (ISR -23%) takes a hit after it announces a direct placement of...</a></h4><p>Microcap Med-tech company IsoRay (<a href=\"https://seekingalpha.com/symbol/ISR\" title=\"IsoRay, Inc.\">ISR</a> <font color=\"red\">-23%</font>) takes a hit after it announces a direct placement of approximately $3.5M shares at a price of $0.965 per share. a 34% discount to Friday's closing price. The company plans to use the proceeds to fund marketing efforts for its GliaSite, and new emerging cancer solutions for internal radiation therapy. </p><div class=\"tiny-share-widget\" data-id=\"416131\" data-linked=\"Microcap Med-tech company IsoRay (ISR -23%) takes a hit after it announces a direct placement of...\" data-tweet=\"$ISR - Microcap Med-tech company IsoRay (ISR -23%) takes a hit after it announces a direct placement of approximately $3.5M shares at a price of $0.965 per share. a 34% discount to Friday&#39;s closing price. The company plans to use the proceeds to fund ma... https://seekingalpha.com/news/416131?source=tweet\" data-url=\"https://seekingalpha.com/news/416131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416081\" data-ts=\"1342449871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BID\" target=\"_blank\">BID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sotheby&#39;s (BID -5.1%) trades weak after Craig-Hallum takes its rating on the auction house down...</a></h4>Sotheby's (<a href='https://seekingalpha.com/symbol/BID' title='Sotheby&#39;s'>BID</a> <font color=\"red\">-5.1%</font>) trades weak after Craig-Hallum takes its rating on the auction house <a target=\"_blank\" href=\"http://www.dividend.com/blog/?p=50001\">down</a> to Hold from Buy. Growth headwinds in China for Sotheby's and its upcoming tough comparables has the investment firm sitting on the sidelines for the time being.<div class=\"tiny-share-widget\" data-id=\"416081\" data-linked=\"Sotheby&#39;s (BID -5.1%) trades weak after Craig-Hallum takes its rating on the auction house down...\" data-tweet=\"$BID - Sotheby&#39;s (BID -5.1%) trades weak after Craig-Hallum takes its rating on the auction house down to Hold from Buy. Growth headwinds in China for Sotheby&#39;s and its upcoming tough comparables has the investment firm sitting on the sidelines for the ... https://seekingalpha.com/news/416081?source=tweet\" data-url=\"https://seekingalpha.com/news/416081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416051\" data-ts=\"1342449552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar (FSLR +4.7%) rallies after announcing NRG Energy&#39;s (NYSE:NRG) Agua Caliente solar...</a></h4><p>First Solar (<a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"green\">+4.7%</font>) rallies after announcing NRG Energy's (NYSE:<a href=\"https://seekingalpha.com/symbol/NRG\" title=\"NRG Energy, Inc.\">NRG</a>) Agua Caliente solar plant, in which Berkshire Hathaway's MidAmerican Energy has <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/106202\">taken a 49% stake</a>, is now more than 2/3 complete, and has over 200MW of installed capacity. Agua Caliente, which has received a DOE loan guarantee and is being constructed and operated by First Solar, is expected to be completed in 2014. (PR) </p><div class=\"tiny-share-widget\" data-id=\"416051\" data-linked=\"First Solar (FSLR +4.7%) rallies after announcing NRG Energy&#39;s (NYSE:NRG) Agua Caliente solar...\" data-tweet=\"$FSLR $FSLR $NRG - First Solar (FSLR +4.7%) rallies after announcing NRG Energy&#39;s (NYSE:NRG) Agua Caliente solar plant, in which Berkshire Hathaway&#39;s MidAmerican Energy has taken a 49% stake, is now more than 2/3 complete, and has over 200MW of installe... https://seekingalpha.com/news/416051?source=tweet\" data-url=\"https://seekingalpha.com/news/416051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416041\" data-ts=\"1342449527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JRCCQ\" target=\"_blank\">JRCCQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">James River Coal (JRCC +7.2%) enjoys a nice bounce following Friday&#39;s 11% slide on expectations...</a></h4><p>James River Coal (JRCC <font color=\"green\">+7.2%</font>) enjoys a nice bounce following <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/414151\">Friday's 11% slide</a> on expectations of lower Q3 coal production from peer Consol Energy (<a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"red\">-2.2%</font>). </p><div class=\"tiny-share-widget\" data-id=\"416041\" data-linked=\"James River Coal (JRCC +7.2%) enjoys a nice bounce following Friday&#39;s 11% slide on expectations...\" data-tweet=\"$JRCCQ $JRCCQ $CNX - James River Coal (JRCC +7.2%) enjoys a nice bounce following Friday&#39;s 11% slide on expectations of lower Q3 coal production from peer Consol Energy (CNX -2.2%). https://seekingalpha.com/news/416041?source=tweet\" data-url=\"https://seekingalpha.com/news/416041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"416011\" data-ts=\"1342448339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NCR\" target=\"_blank\">NCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/416011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NCR gains 3.6% after Barron&#39;s argues sales of the company&#39;s point-of-sale &amp;#40;POS&amp;#41; systems...</a></h4><a href=\"https://seekingalpha.com/symbol/NCR\" title=\"NCR Corporation\">NCR</a> <font color=\"green\">gains 3.6%</font> after <em>Barron's </em><a target=\"_blank\" href=\"http://www.reuters.com/article/2012/07/15/ncr-stock-idUSL2E8IF1W020120715?feedType=RSS&amp;feedName=financialsSector&amp;rpc=43\">argues</a> sales of the company's point-of-sale (POS) systems will fare well in a low-growth environment, due to their high return on investment. Strong emerging markets exposure, new banking hardware solutions, and a diverse product line are seen as offsetting hefty pension obligations. <div class=\"tiny-share-widget\" data-id=\"416011\" data-linked=\"NCR gains 3.6% after Barron&#39;s argues sales of the company&#39;s point-of-sale (POS) systems will...\" data-tweet=\"$NCR - NCR gains 3.6% after Barron&#39;s argues sales of the company&#39;s point-of-sale (POS) systems will fare well in a low-growth environment, due to their high return on investment. Strong emerging markets exposure, new banking hardware solutions, and a di... https://seekingalpha.com/news/416011?source=tweet\" data-url=\"https://seekingalpha.com/news/416011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415971\" data-ts=\"1342447703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of a number of restaurant chain operators trade lower after Piper Jaffray hits Panera...</a></h4>Shares of a number of restaurant chain operators trade lower after Piper Jaffray hits Panera Bread and Sonic (<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color=\"red\">-4.6%</font>) with <a target=\"_blank\" target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415441\">harsh two-level downgrades</a>. Though analysts with Piper cite specific execution risks at both companies, the sentiment in the actions seems to have filtered down to hit smaller-sized names in the sector. <a href='https://seekingalpha.com/symbol/BAGL' title='Einstein Noah Restaurant Group, Inc.'>BAGL</a> <font color=\"red\">-2.7%</font>, THI <font color=\"red\">-2.5%</font>, <a href='https://seekingalpha.com/symbol/NATH' title='Nathan&#39;s Famous, Inc.'>NATH</a> <font color=\"red\">-2.6%</font>, <a href='https://seekingalpha.com/symbol/CBOU' title='Caribou Coffee Company, Inc.'>CBOU</a> <font color=\"red\">-2.3%</font>, PZZI <font color=\"red\">-3.3%</font>, <a href='https://seekingalpha.com/symbol/DPZ' title='Domino&#39;s Pizza, Inc.'>DPZ</a> <font color=\"red\">-1.7%</font>.<div class=\"tiny-share-widget\" data-id=\"415971\" data-linked=\"Shares of a number of restaurant chain operators trade lower after Piper Jaffray hits Panera...\" data-tweet=\"$SONC $SONC $BAGL - Shares of a number of restaurant chain operators trade lower after Piper Jaffray hits Panera Bread and Sonic (SONC -4.6%) with harsh two-level downgrades. Though analysts with Piper cite specific execution risks at both companies, th... https://seekingalpha.com/news/415971?source=tweet\" data-url=\"https://seekingalpha.com/news/415971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415881\" data-ts=\"1342446336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on GSK-Human Genome deal. GSK (GSK +0.2%) finally gets HGS (HGSI +3%) after a protracted...</a></h4><p>More on GSK-Human Genome <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415841\">deal</a>. GSK (<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a> <font color=\"green\">+0.2%</font>) finally gets HGS (<a href=\"https://seekingalpha.com/symbol/HGSI\" title=\"\">HGSI</a> <font color=\"green\">+3%</font>) after a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=human%20genome%20gsk\">protracted fight</a> and increasing the offer from $2.8B or $13/share. While the deal is worth $3.6B on an equity basis, it's valued at $3B net of cash and debt. The $14.25/share offer is almost double HGSI's closing price of $7.17 on 18 April, just prior to GSK's initial proposal being made public. (PR) </p><div class=\"tiny-share-widget\" data-id=\"415881\" data-linked=\"More on GSK-Human Genome deal. GSK (GSK +0.2%) finally gets HGS (HGSI +3%) after a protracted...\" data-tweet=\"$GSK - More on GSK-Human Genome deal. GSK (GSK +0.2%) finally gets HGS (HGSI +3%) after a protracted fight and increasing the offer from $2.8B or $13/share. While the deal is worth $3.6B on an equity basis, it&#39;s valued at $3B net of cash and debt. The $... https://seekingalpha.com/news/415881?source=tweet\" data-url=\"https://seekingalpha.com/news/415881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415871\" data-ts=\"1342446156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUTH\" target=\"_blank\">AUTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AuthenTec (AUTH +12.2%) jumps after announcing Samsung (OTC:SSNLF) is integrating the company&#39;s...</a></h4><p>AuthenTec (<a href=\"https://seekingalpha.com/symbol/AUTH\" title=\"AuthenTec, Inc.\">AUTH</a> <font color=\"green\">+12.2%</font>) jumps after announcing Samsung (<a href=\"https://seekingalpha.com/symbol/SSNLF\" title=\"Samsung Electronics Co., Ltd.\">OTC:SSNLF</a>) is integrating the company's <a target=\"_blank\" href=\"http://www.authentec.com/Products/EmbeddedSecurity/SemiconductorIP/QuickSecIPsecClientToolkit.aspx\">QuickSec</a> VPN software in its Android phones and tablets. Samsung has an increasingly dominant share of the Android smartphone market (particularly on the high-end), and is <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/372561\">stepping up its efforts</a> to outfit its phones with the security and device-management features sought by enterprises. (PR) </p><div class=\"tiny-share-widget\" data-id=\"415871\" data-linked=\"AuthenTec (AUTH +12.2%) jumps after announcing Samsung (OTC:SSNLF) is integrating the company&#39;s...\" data-tweet=\"$AUTH $AUTH $SSNLF - AuthenTec (AUTH +12.2%) jumps after announcing Samsung (OTC:SSNLF) is integrating the company&#39;s QuickSec VPN software in its Android phones and tablets. Samsung has an increasingly dominant share of the Android smartphone market (pa... https://seekingalpha.com/news/415871?source=tweet\" data-url=\"https://seekingalpha.com/news/415871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415841\" data-ts=\"1342445519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GlaxoSmithKline (NYSE:GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a...</a></h4><p>GlaxoSmithKline (NYSE:<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>) agrees to acquire Human Genome Sciences (<a href=\"https://seekingalpha.com/symbol/HGSI\" title=\"\">HGSI</a>) for $3.6B, or $14.25 a share. HGSI shares <font color=\"green\">+3%</font>. (PR) </p><div class=\"tiny-share-widget\" data-id=\"415841\" data-linked=\"GlaxoSmithKline (NYSE:GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a...\" data-tweet=\"$GSK - GlaxoSmithKline (NYSE:GSK) agrees to acquire Human Genome Sciences (HGSI) for $3.6B, or $14.25 a share. HGSI shares +3%. (PR) https://seekingalpha.com/news/415841?source=tweet\" data-url=\"https://seekingalpha.com/news/415841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415821\" data-ts=\"1342445373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zogenix (NASDAQ:ZGNX) +10.4% premarket after the drug maker says the FDA had accepted for review...</a></h4><p>Zogenix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ZGNX\" title=\"Zogenix, Inc.\">ZGNX</a>) <font color=\"green\">+10.4%</font> premarket after the drug maker says the FDA  had accepted for review its lead investigational product candidate for the treatment of chronic pain. The goal for a standard review of a new drug application is 10 months from submission, and the FDA has assigned a target action date of March 1,  2013 for the Zohydro ER NDA. </p><div class=\"tiny-share-widget\" data-id=\"415821\" data-linked=\"Zogenix (NASDAQ:ZGNX) +10.4% premarket after the drug maker says the FDA had accepted for review...\" data-tweet=\"$ZGNX - Zogenix (NASDAQ:ZGNX) +10.4% premarket after the drug maker says the FDA had accepted for review its lead investigational product candidate for the treatment of chronic pain. The goal for a standard review of a new drug application is 10 months ... https://seekingalpha.com/news/415821?source=tweet\" data-url=\"https://seekingalpha.com/news/415821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415781\" data-ts=\"1342445063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSPH\" target=\"_blank\">NSPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415781\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nanosphere (NASDAQ:NSPH) -5% premarket after issuing downside guidance for Q2. NSPH sees Q2...</a></h4><p>Nanosphere (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NSPH\" title=\"Nanosphere, Inc.\">NSPH</a>) <font color=\"red\">-5%</font> premarket after issuing downside guidance for Q2. NSPH sees Q2 revenues of $1.3M, +160% Y/Y but lower than the consensus estimate of $1.5M. Customer placements totaled 25, bringing cumulative placements to 166. </p><div class=\"tiny-share-widget\" data-id=\"415781\" data-linked=\"Nanosphere (NASDAQ:NSPH) -5% premarket after issuing downside guidance for Q2. NSPH sees Q2...\" data-tweet=\"$NSPH - Nanosphere (NASDAQ:NSPH) -5% premarket after issuing downside guidance for Q2. NSPH sees Q2 revenues of $1.3M, +160% Y/Y but lower than the consensus estimate of $1.5M. Customer placements totaled 25, bringing cumulative placements to 166. https://seekingalpha.com/news/415781?source=tweet\" data-url=\"https://seekingalpha.com/news/415781\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415761\" data-ts=\"1342444796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu (NYSE:SVU) moves 6.1% higher premarket after Goldman Sachs chimes in with an upgrade...</a></h4><p>Supervalu (NYSE:<a href=\"https://seekingalpha.com/symbol/SVU\" title=\"SUPERVALU Inc.\">SVU</a>) moves <font color=\"red\">6.1% higher</font> premarket after Goldman Sachs chimes in with an <a target=\"_blank\" href=\"http://www.streetinsider.com/Hot+Upgrades/Goldman+Sachs+Upgrades+SUPERVALU+%28SVU%29+to+Neutral,+Sell-Off+Overdone/7580473.html\">upgrade</a> to Neutral from Sell. The firm says last week's selloff in shares brings the stock's risk-reward profile back in balance.</p><div class=\"tiny-share-widget\" data-id=\"415761\" data-linked=\"Supervalu (NYSE:SVU) moves 6.1% higher premarket after Goldman Sachs chimes in with an upgrade...\" data-tweet=\"$SVU - Supervalu (NYSE:SVU) moves 6.1% higher premarket after Goldman Sachs chimes in with an upgrade to Neutral from Sell. The firm says last week&#39;s selloff in shares brings the stock&#39;s risk-reward profile back in balance. https://seekingalpha.com/news/415761?source=tweet\" data-url=\"https://seekingalpha.com/news/415761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415741\" data-ts=\"1342444546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: Stock futures maintain their losses after retail sales unexpectedly contract and...</a></h4><b>Market preview:</b> Stock futures <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424052702303754904577530412943274438.html\">maintain their losses</a> after <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415561\">retail sales</a> unexpectedly contract and despite decent <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415571\">manufacturing data</a> out of New York, with the S&amp;P Benchmark <font color=\"red\">-0.3%</font>. Citigroup is <font color=\"green\">+4.1%</font> following <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415521\">earnings</a> , although Woodward is <font color=\"red\">-16.8%</font> after a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415661\">profit warning</a>. Visa (<font color=\"green\">+2.65%</font>) and MasterCard (<font color=\"green\">+2.2%</font>) make steady gains in the wake of their <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/414761\">$7.25B settlement</a> with merchants. <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/414631\">Later</a>: Business Inventories <div class=\"tiny-share-widget\" data-id=\"415741\" data-linked=\"Market preview: Stock futures maintain their losses after retail sales unexpectedly contract and...\" data-tweet=\"Market preview: Stock futures maintain their losses after retail sales unexpectedly contract and despite decent manufacturing data out of New York, with the S&amp;P Benchmark -0.3%. Citigroup is +4.1% following earnings , although Woodward is -16.8% after a... https://seekingalpha.com/news/415741?source=tweet\" data-url=\"https://seekingalpha.com/news/415741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415721\" data-ts=\"1342444291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415721\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam Pharmaceuticals (NASDAQ:ALNY) +9.4% premarket after the biotech firm says a study showed...</a></h4><p>Alnylam Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ALNY\" title=\"Alnylam Pharmaceuticals, Inc.\">ALNY</a>) <font color=\"green\">+9.4%</font> premarket after the biotech firm says a study showed ALN-TTR02, a  potential treatment for a genetic mutation of the transthyretin gene,  reduced serum TTR protein levels in a way that was \"rapid, dose dependent, durable, and specific after just a single dose.\" </p><div class=\"tiny-share-widget\" data-id=\"415721\" data-linked=\"Alnylam Pharmaceuticals (NASDAQ:ALNY) +9.4% premarket after the biotech firm says a study showed...\" data-tweet=\"$ALNY - Alnylam Pharmaceuticals (NASDAQ:ALNY) +9.4% premarket after the biotech firm says a study showed ALN-TTR02, a potential treatment for a genetic mutation of the transthyretin gene, reduced serum TTR protein levels in a way that was &quot;rapid, dose d... https://seekingalpha.com/news/415721?source=tweet\" data-url=\"https://seekingalpha.com/news/415721\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415711\" data-ts=\"1342444232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRX\" target=\"_blank\">PRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: PRX +39%. CONM +13%. AUTH +13%. SVU +6%. Losers: ISR -19%. NSPH -6%. ANR -6%.</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/PRX\" title=\"Par Pharmaceutical Companies, Inc.\">PRX</a> <font color=\"green\">+39%</font>. <a href=\"https://seekingalpha.com/symbol/CONM\" title=\"Conmed Healthcare Management Inc\">CONM</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/AUTH\" title=\"AuthenTec, Inc.\">AUTH</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/SVU\" title=\"SUPERVALU Inc.\">SVU</a> <font color=\"green\">+6%</font>.<br> <b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ISR\" title=\"IsoRay, Inc.\">ISR</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/NSPH\" title=\"Nanosphere, Inc.\">NSPH</a> <font color=\"red\">-6%</font>. ANR <font color=\"red\">-6%</font>. <div class=\"tiny-share-widget\" data-id=\"415711\" data-linked=\"Premarket gainers: PRX +39%. CONM +13%. AUTH +13%. SVU +6%. Losers: ISR -19%. NSPH -6%. ANR -6%.\" data-tweet=\"$PRX $PRX $CONM - Premarket gainers: PRX +39%. CONM +13%. AUTH +13%. SVU +6%. Losers: ISR -19%. NSPH -6%. ANR -6%. https://seekingalpha.com/news/415711?source=tweet\" data-url=\"https://seekingalpha.com/news/415711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415661\" data-ts=\"1342443556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWD\" target=\"_blank\">WWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415661\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of aerospace and defense industry supplier Woodward (NASDAQ:WWD) fall 20.2% premarket...</a></h4><p>Shares of aerospace and defense industry supplier Woodward (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WWD\" title=\"Woodward, Inc.\">WWD</a>) <font color=\"red\">fall 20.2%</font> premarket after the company cuts estimates for Q3 below the consensus forecast from analysts. The company now sees revenue of $460M and EPS of $0.40 for the quarter due to weak demand in the sector.</p><div class=\"tiny-share-widget\" data-id=\"415661\" data-linked=\"Shares of aerospace and defense industry supplier Woodward (NASDAQ:WWD) fall 20.2% premarket...\" data-tweet=\"$WWD - Shares of aerospace and defense industry supplier Woodward (NASDAQ:WWD) fall 20.2% premarket after the company cuts estimates for Q3 below the consensus forecast from analysts. The company now sees revenue of $460M and EPS of $0.40 for the quarte... https://seekingalpha.com/news/415661?source=tweet\" data-url=\"https://seekingalpha.com/news/415661\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415621\" data-ts=\"1342443117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCI\" target=\"_blank\">GCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Gannett&#39;s (NYSE:GCI) Q2: Publishing advertising revenue slipped 8.1% Y/Y to $594M, while...</a></h4><p>More on Gannett's (NYSE:<a href=\"https://seekingalpha.com/symbol/GCI\" title=\"Gannett Co., Inc.\">GCI</a>) Q2: Publishing advertising revenue slipped 8.1% Y/Y to $594M, while broadcast revenue gained 11.4% to $205M. Page views of the company's mobile news apps +154% Y/Y. Sees strong demand for digital marketing services contributing to results. Shares <font color=\"green\">+1.4%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"415621\" data-linked=\"More on Gannett&#39;s (NYSE:GCI) Q2: Publishing advertising revenue slipped 8.1% Y/Y to $594M, while...\" data-tweet=\"$GCI - More on Gannett&#39;s (NYSE:GCI) Q2: Publishing advertising revenue slipped 8.1% Y/Y to $594M, while broadcast revenue gained 11.4% to $205M. Page views of the company&#39;s mobile news apps +154% Y/Y. Sees strong demand for digital marketing services co... https://seekingalpha.com/news/415621?source=tweet\" data-url=\"https://seekingalpha.com/news/415621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415611\" data-ts=\"1342442986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/E\" target=\"_blank\">E</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415611\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eni (NYSE:E) -1.7% premarket after shareholders approve scrapping the Italian oil and gas...</a></h4><p>Eni (NYSE:<a href=\"https://seekingalpha.com/symbol/E\" title=\"ENI S.p.A.\">E</a>) <font color=\"red\">-1.7%</font> premarket after shareholders approve <a target=\"_blank\" href=\"http://online.wsj.com/article/BT-CO-20120716-702245.html\">scrapping</a> the Italian oil and gas company's treasury shares as part of a share buyback program. Also, the company says it expects to make a <a target=\"_blank\" href=\"http://online.wsj.com/article/BT-CO-20120716-702563.html\">final decision</a> in late 2012 or early 2013 on the South Stream natural gas pipeline project envisioned to carry up to 63B/year cubic meters of Russian gas under the Black Sea to Europe. </p><div class=\"tiny-share-widget\" data-id=\"415611\" data-linked=\"Eni (NYSE:E) -1.7% premarket after shareholders approve scrapping the Italian oil and gas...\" data-tweet=\"$E - Eni (NYSE:E) -1.7% premarket after shareholders approve scrapping the Italian oil and gas company&#39;s treasury shares as part of a share buyback program. Also, the company says it expects to make a final decision in late 2012 or early 2013 on the Sou... https://seekingalpha.com/news/415611?source=tweet\" data-url=\"https://seekingalpha.com/news/415611\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415551\" data-ts=\"1342441800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANRZQ\" target=\"_blank\">ANRZQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alpha Natural Resources (ANR) and Arch Coal (NYSE:ACI) gap lower in premarket trading after both...</a></h4><p>Alpha Natural Resources (ANR) and Arch Coal (NYSE:<a href=\"https://seekingalpha.com/symbol/ACI\" title=\"Albertsons Companies Inc\">ACI</a>) gap lower in premarket trading after both coal companies are downgraded (<a target=\"_blank\" href=\"http://finance.yahoo.com/news/alpha-natural-downgraded-underperform-outperform-102246132.html\">I</a>, <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/BMO+Capital+Downgrades+Arch+Coal+Inc+%28ACI%29+to+Underperform/7580105.html\">II</a>) to Underperform at BMOCapital, based on weak Appalachian coal demand, high debt levels and deteriorating margins. ANR <font color=\"red\">-5.4%</font>, ACI <font color=\"red\">-5.8%</font> premarket. </p><div class=\"tiny-share-widget\" data-id=\"415551\" data-linked=\"Alpha Natural Resources (ANR) and Arch Coal (NYSE:ACI) gap lower in premarket trading after both...\" data-tweet=\"$ANRZQ $ANRZQ $ARCH - Alpha Natural Resources (ANR) and Arch Coal (NYSE:ACI) gap lower in premarket trading after both coal companies are downgraded (I, II) to Underperform at BMOCapital, based on weak Appalachian coal demand, high debt levels and dete... https://seekingalpha.com/news/415551?source=tweet\" data-url=\"https://seekingalpha.com/news/415551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415541\" data-ts=\"1342441495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRX\" target=\"_blank\">PRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415541\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TPG agrees to acquire Par Pharmaceutical (NYSE:PRX) for $1.9B, or $50/share, which represents a...</a></h4><p>TPG agrees to acquire Par Pharmaceutical (NYSE:<a href=\"https://seekingalpha.com/symbol/PRX\" title=\"Par Pharmaceutical Companies, Inc.\">PRX</a>) for $1.9B, or $50/share, which represents a 37% premium over Par's closing price on Friday. Shares <font color=\"green\">+36%</font> premarket. (PR) </p><div class=\"tiny-share-widget\" data-id=\"415541\" data-linked=\"TPG agrees to acquire Par Pharmaceutical (NYSE:PRX) for $1.9B, or $50/share, which represents a...\" data-tweet=\"$PRX - TPG agrees to acquire Par Pharmaceutical (NYSE:PRX) for $1.9B, or $50/share, which represents a 37% premium over Par&#39;s closing price on Friday. Shares +36% premarket. (PR) https://seekingalpha.com/news/415541?source=tweet\" data-url=\"https://seekingalpha.com/news/415541\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415431\" data-ts=\"1342438410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/V\" target=\"_blank\">V</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415431\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumers will see extra charges when they use plastic as a byproduct of the massive settlement...</a></h4><p>Consumers will see extra charges when they use plastic as a byproduct of the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/414761\">massive settlement</a> between retailers and credit card companies. Merchants have wider authority to add a surcharge for credit card transactions as part of the historic deal. Premarket: <a href=\"https://seekingalpha.com/symbol/V\" title=\"Visa Inc.\">V</a> <font color=\"green\">+3.2%</font>, <a href=\"https://seekingalpha.com/symbol/MA\" title=\"Mastercard, Inc.\">MA</a> <font color=\"green\">+4.1%</font>, <a href=\"https://seekingalpha.com/symbol/AXP\" title=\"American Express Company\">AXP</a> <font color=\"green\">+0.4%</font>.</p><div class=\"tiny-share-widget\" data-id=\"415431\" data-linked=\"Consumers will see extra charges when they use plastic as a byproduct of the massive settlement...\" data-tweet=\"$V $V $MA - Consumers will see extra charges when they use plastic as a byproduct of the massive settlement between retailers and credit card companies. Merchants have wider authority to add a surcharge for credit card transactions as part of the histor... https://seekingalpha.com/news/415431?source=tweet\" data-url=\"https://seekingalpha.com/news/415431\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"415131\" data-ts=\"1342422389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZTCOF\" target=\"_blank\">ZTCOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/415131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Despite hopes of additional stimulus, Chinese stocks fell heavily on earnings concerns;...</a></h4><p>Despite <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/415121\">hopes</a> of additional stimulus, Chinese stocks fell heavily on earnings concerns; benchmark index <font color=\"red\">-1.8%</font>. In particular, ZTE Corp., China's second-largest telecom maker, fell by the daily trading limit of 10% after warning H1 profits may have <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-07-16/zte-falls-most-since-2008-as-net-may-drop-80-hong-kong-mover.html\">declined as much as 80%</a>. </p><div class=\"tiny-share-widget\" data-id=\"415131\" data-linked=\"Despite hopes of additional stimulus, Chinese stocks fell heavily on earnings concerns;...\" data-tweet=\"$ZTCOF $ZTCOF $ZTCOY - Despite hopes of additional stimulus, Chinese stocks fell heavily on earnings concerns; benchmark index -1.8%. In particular, ZTE Corp., China&#39;s second-largest telecom maker, fell by the daily trading limit of 10% after warning H1... https://seekingalpha.com/news/415131?source=tweet\" data-url=\"https://seekingalpha.com/news/415131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":56,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}